Cancer Biotech Apellis Pharma Sets Terms for $150M IPO
The Crestwood, KY-based company plans to raise $150M by offering 10.7 million shares at a price range of $13 to $15.
Source: BioSpace
The Crestwood, KY-based company plans to raise $150M by offering 10.7 million shares at a price range of $13 to $15.
Source: BioSpace